Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash from Operations (2016 - 2026)

Standard Biotools has reported Cash from Operations over the past 16 years, most recently at 1190000.0 for Q4 2025.

  • Quarterly Cash from Operations rose 91.54% to 1190000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 74343000.0 through Dec 2025, up 48.18% year-over-year, with the annual reading at 74343000.0 for FY2025, 48.18% up from the prior year.
  • Cash from Operations was 1190000.0 for Q4 2025 at Standard Biotools, up from 22202000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1190000.0 in Q4 2025 and troughed at 62476000.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 20668000.0 (2025), against an average of 22525210.53.
  • Year-over-year, Cash from Operations tumbled 887.99% in 2021 and then skyrocketed 91.54% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 37059000.0 in 2021, then surged by 48.24% to 19181000.0 in 2022, then rose by 26.69% to 14061000.0 in 2023, then rose by 0.01% to 14059000.0 in 2024, then skyrocketed by 91.54% to 1190000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Cash from Operations are 1190000.0 (Q4 2025), 22202000.0 (Q3 2025), and 20668000.0 (Q2 2025).